Endo Boosts Urology Device Presence With $2.9 Billion AMS Bid
This article was originally published in The Gray Sheet
Executive Summary
Endo Pharmaceuticals has made its second big jump into the urology device space in less than a year, announcing April 11 that it will pay $2.9 billion in cash for American Medical Systems.